ClinicalTrials.Veeva

Menu

Early Identification and Prevention of Extubation Failure in Adults Using Integrated Pulmonary Index (IPI)

Rush logo

Rush

Status

Completed

Conditions

Mechanical Ventilation Complication
Extubation

Treatments

Other: IPI monitoring

Study type

Interventional

Funder types

Other

Identifiers

NCT04231890
18112803

Details and patient eligibility

About

The primary aim of this study is to compare reintubation rate when using standard medical therapy (SMT) versus a monitoring tool, Integrated Pulmonary Index (IPI), to alert clinicians of the patient's respiratory status and need for therapy after planned extubation.

Full description

The study is designed as a randomized controlled trial to compare two methods to guide application of clinical interventions after planned extubation: SMT versus IPI based clinical management among adult patients admitted in the ICU and receiving mechanical ventilation for ≥24 hours. Each mechanically ventilated subject within the inclusion criteria and with a physician order for extubation will be randomized to either the SMT or IPI based clinical management group. Once the extubation order is placed by the medical team, the patient will be randomized to IPI monitoring group or standard medical management group. Patients randomized to IPI group will be placed on IPI monitoring after extubation.Respiratory Therapist (RT) will extubate and connects the patient to EtCO2 cannula (Medtronic, Minneapolis, MN) and will turn on IPI monitoring on the Philips monitor. Any subject with decrease in IPI by 1 within 1 hour of extubation or IPI ≤ 4 after 1 hour of extubation will be assessed by RT and will receive standard medical therapy based on respiratory department protocols. IPI monitoring will be continued for up to 72 hours after extubation. Patients randomized to control group will receive standard medical therapy based on the respiratory department protocols. All patients will be clinically monitored for 72 hours after extubation to assess the extubation outcome. Patients that require reintubation will be reintubated based on the medical team decision and will be discontinued from the study. Patients that do not require reintubation after 72 hours will successfully complete the study.

Enrollment

174 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult subjects 18 years and older, endotracheally intubated and receiving assisted mechanical ventilation for more than 24hours, and
  • Subjects under planned extubation based on the medical team approval

Exclusion criteria

  • Subjects who are less than 18 years old,
  • are pregnant,
  • have tracheostomy tube as they do not qualify for extubation,
  • have do-not-resuscitate or do-not-intubate orders,
  • accidental or self-extubated patients,
  • reintubation after study enrollment,
  • are extubated terminally, or
  • receiving extracorporeal membrane oxygenation (ECMO)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

174 participants in 2 patient groups

IPI group
Experimental group
Description:
IPI monitoring
Treatment:
Other: IPI monitoring
Control group
No Intervention group
Description:
Standard monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems